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Recent literature has presented evidence that cardiovascular risk factors (CVRF) play an
important role on cognitive performance in elderly individuals, both those who are asymp-
tomatic and those who suffer from symptoms of neurodegenerative disorders. Findings
from studies applying neuroimaging methods have increasingly reinforced such notion.
Studies addressing the impact of CVRF on brain anatomy changes have gained increas-
ing importance, as recent papers have reported gray matter loss predominantly in regions
traditionally affected in Alzheimer’s disease (AD) and vascular dementia in the presence
of a high degree of cardiovascular risk. In the present paper, we explore the association
between CVRF and brain changes using pattern recognition techniques applied to structural
MRI and the Framingham score (a composite measure of cardiovascular risk largely used
in epidemiological studies) in a sample of healthy elderly individuals. We aim to answer
the following questions: is it possible to decode (i.e., to learn information regarding cardio-
vascular risk from structural brain images) enabling individual predictions? Among clinical
measures comprising the Framingham score, are there particular risk factors that stand
as more predictable from patterns of brain changes? Our main findings are threefold: (i)
we verified that structural changes in spatially distributed patterns in the brain enable sta-
tistically significant prediction of Framingham scores. This result is still significant when
controlling for the presence of the APOE 4 allele (an important genetic risk factor for both
AD and cardiovascular disease). (ii) When considering each risk factor singly, we found
different levels of correlation between real and predicted factors; however, single factors
were not significantly predictable from brain images when considering APOE4 allele pres-
ence as covariate. (iii) We found important gender differences, and the possible causes of
that finding are discussed.
Keywords: Framingham score, cardiovascular risk factors, magnetic resonance imaging, pattern recognition,
multivariate analysis
INTRODUCTION
Cardiovascular risk factors (CVRF) such as hypertension, diabetes,
dyslipidemia, and smoking, are highly prevalent in the elderly pop-
ulation and have significant impact on cognitive performance. In
the last years, effects of CVRF on brain morphology have been
widely investigated using neuroimaging resources. A number of
morphometric studies using magnetic resonance imaging (MRI)
(Korf et al., 2007; Almeida et al., 2008; Chen et al., 2012; Beauchet
et al., 2013) have found decreased gray matter (GM) volumes in
direct proportion to the degree of cardiovascular risk in otherwise
healthy elderly individuals. In addition, studies using functional
imaging methods such as positron emission tomography (PET)
or functional MRI (fMRI) (Minoshima et al., 1997; Chetelat et al.,
2003; Jagust, 2006; Kawachi et al., 2006; Mosconi et al., 2007;
Marchand et al.,2011) have reported brain activity deficits also cor-
related with cardiovascular risk. These neuroimaging alterations
often involve brain regions known to be implicated in the patho-
physiology of Alzheimer’s disease (AD), such as the hippocampal
region, posterior cingulate gyrus, temporal, and parietal cortices
(Korf et al., 2004; Seshadri et al., 2004; Riello et al., 2005; Chen
et al., 2006; Viswanathan et al., 2009; Neufang et al., 2011, 2013;
Rasgon et al., 2011). Thus, such findings have provided critical
support to the notion that the degree of cardiovascular risk may
be a key influence in the development and course of AD.
Several studies applying neuroimaging to investigate the impact
of cardiovascular risk on the brain have one important lim-
itation, namely to consider each factor singly. As CVRF are
widely known to seldom appear in isolation (Wilson et al., 1998;
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Jeerakathil et al., 2004; Seshadri, 2006; Razay et al., 2007), the
influence of combined CVRF in imaging studies is likely to
improve sensitivity to such investigations. Recently, our group
examined GM changes in structural MRI data from elderly sub-
jects with different degrees of cardiovascular risk (de Toledo Ferraz
Alves et al., 2011) using the Framingham Coronary Heart Disease
Risk [FCHDR (Grundy et al., 1998; Wilson et al., 1998)] score,
a composite index comprising five clinical factors (age, blood
pressure, diabetes mellitus, smoking status, and cholesterol lev-
els). Given recent findings regarding cardiovascular risk effects
on cognitive performance (Mosconi, 2005; Obisesan et al., 2008;
Fitzpatrick et al., 2009; Purandare, 2009; Scarmeas et al., 2009;
Buchman et al., 2012), the FCHDR score has presented excellent
potential for investigations involving brain imaging (Elias et al.,
2003; Jeerakathil et al., 2004; Massaro et al., 2004; Seshadri et al.,
2004; DeCarli et al., 2005; Romero et al., 2009).
For the study by de Toledo Ferraz Alves et al. (2011), dementia-
free individuals aged from 66 to 75 years were recruited from the
database “São Paulo Aging and Health Study” (SPAH) (Scazufca
and Seabra, 2008; Scazufca et al., 2008) and divided into three
subgroups (high-risk, medium-risk, and low-risk) according to
their FCHDR scores and gender (Table 1). Analyses of covariance
were performed to investigate the presence of mean regional GM
volume differences between the subgroups, followed by post hoc
t -tests.
Using voxel-based morphometry (VBM) (Ashburner and Fris-
ton, 2000), the authors showed that the presence of CVRF was
associated with mean regional GM loss involving the lateral tem-
poral cortices bilaterally. They also observed a negative correlation
between FCHDR scores and regional GM distribution in the lateral
parietal cortex. Both areas are considered critical to pathophysi-
ology of AD (Garrido et al., 2002; Mosconi et al., 2007; Yakushev
et al., 2009; Ystad et al., 2009).
Several studies in this area do not take into account information
regarding the major genetic risk factor for AD – the epsilon 4 (ε4)
variant of the gene encoding the apolipoprotein E (APOE allele 4,
APOE *4, or APOE 4) (Reiman, 2007; Cherbuin et al., 2008). This
is a limitation since the presence of the APOE-4 allele carrier is also
a risk factor for cardiovascular diseases and may be associated with
variations in brain structure and functioning, even in non-elderly
adults (Kivipelto et al., 2008). In our previous VBM investiga-
tion (de Toledo Ferraz Alves et al., 2011), regional GM differences
across groups retained significance when considering the APOE
4 allele as a covariate of interest. This finding brought additional
support to the hypothesis of a direct effect of CVRF on the brain,
and consequently, a possible non-genetically determined influ-
ence on the development of AD-like brain abnormalities caused
by microvascular-related changes in the general population.
The results of our previous investigation are, however, likely
to have been influenced by common limitations in brain imaging
studies. These include the increased chance of type I errors due
to the large number of statistical comparisons across the entire
brain, as well as the univariate, voxel-by-voxel nature of conven-
tional VBM approaches that force investigators to address brain
abnormalities pertaining to each brain compartment (GM, white
matter, and cerebrospinal fluid space) separately. In the present
study, we aimed to address these limitations using multivariate
Table 1 | Division of subjects in risk groups according to FCHDR in
males and females.
Group Male Female
Low risk Score ≤5 Score ≤9
Medium risk 5< Score ≤8 9< Score ≤14
High risk Score >8 Score >14
analysis. This approach takes into account covariance relations
across brain regions/voxels, rather than a voxel-by-voxel com-
parison. The covariance approach can present greater statistical
power in comparison with univariate techniques, as corrections
for voxel-wise multiple comparisons are not necessary. Addition-
ally, as voxels from the whole brain are modeled together, their
results can be interpreted as a signature of neural networks.
Another critical limitation of conventional VBM studies is
related to their restriction to mean group comparisons, with no
information affordable for individual subjects. Analyses of indi-
vidual subjects are feasible using contemporary pattern recogni-
tion (PR) methods. These methods are relevant as they provide
indices of diagnostic accuracy, and these can be potentially useful
to measure individual risks of favorable outcomes. PR meth-
ods for classification have been increasingly applied in the field
of neurodegenerative dementias. Classifiers using morphometric
MRI data have presented high indices of diagnostic accuracy that
reinforce the diagnosis of AD, the commonest form of dementia
(Vemuri et al., 2008; Magnin et al., 2009; Plant et al., 2010; Dai
et al., 2012; Liu et al., 2012). These techniques have also afforded
promising results in studies related to MCI – cognitive decline
not severe enough to fulfill the criteria for established dementia
(Misra et al., 2009; Aksu et al., 2011; Chincarini et al., 2011; Cui
et al., 2011; Davatzikos et al., 2011; Zhang and Shen, 2012). How-
ever, the latter is still an open area with intense investigations,
as predicting whether individuals who are at increased risk con-
vert to AD is more challenging than classifying AD versus control
individuals.
Given that CVRF are nowadays recognized as important risk
factors for AD, it is relevant to investigate whether PR techniques
are capable of discriminating individuals with variable degrees
of cardiovascular risk based on MRI data. Another important
approach in the present work is to apply a multivariate regres-
sion method in order to evaluate whether it is possible to predict
the FCHDR score individually. Additionally, we explored single
CVRF to investigate if any of those single factors carry enough
information to predict brain changes in these individuals when a
pattern classification approach is applied.
MATERIALS AND METHODS
STUDY SAMPLE
Subjects used in the analysis were described in a previous pub-
lication (de Toledo Ferraz Alves et al., 2011). All subjects were
recruited from a population sample addressed in an epidemi-
ological research program, the SPAH study (Scazufca et al.,
2008).
The inclusion criterion was elderly individuals aged between
66 and 75 years. Exclusion criteria were as follows: (a) presence
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of dementia or minor cognitive impairment; history of stroke,
epilepsy, brain trauma, transitory ischemic events and other neu-
ropsychiatric disorders; and contra-indications for MRI scanning.
After MRI acquisition, additional individuals were excluded due to
different reasons, as artifacts, presence of silent gross brain lesions
identified on the images and individuals for which one or more of
the variables needed to generate the FCHDR score were missing.
Figure 1 presents this information, where the reasons for exclu-
sions, as well as the number of subjects excluded and their gender
distribution were detailed. The study was approved by local ethics
committees, and all subjects gave informed written consent.
Table 2 presents demographic and clinical characteristics for
the final sample of 164 subjects whose MRI scans were used in
the present analyses. For classification, these 164 subjects were
divided into three groups: low, medium, and high cardiovascular
FIGURE 1 | Representation of sample selection and exclusion cases.
The number and gender (M/F) of each subject excluded from the original
sample are presented along with the respective reasons for exclusion.
risk according to their FCHDR score, using the criteria in Table 1
in order to accommodate gender differences.
Genomic DNA was extracted from EDTA-anticoagulated
venous blood using a standard salting-out method and its con-
centration was determined by spectrophotometric measurements.
The single nucleotide polymorphisms (SNPs) rs429358 and rs7412
that determine the three APOE isoforms (APOE ε2, APOE ε3,
and APOE ε4) were genotyped in two different laboratories. Ini-
tially, the genotyping was performed at the laboratory of Genetics
and Pharmacogenetics Program at the Institute of Psychiatry,
University of Sao Paulo. Then, for quality control, the genotyp-
ing was also performed under contract by Prevention Genetics
(www.preventiongenetics.org). The degree of result discrepancy
between the two labs was below 2%.
We report herein the results obtained in the analysis carried
out by Prevention Genetics. Positive APOE4 status was considered
by the presence of at least one allele ε4 in the genotype (i.e., both
heterozygous and homozygous carriers included). In addition, a
Hardy–Weinberg equilibrium test was performed and no statisti-
cally significant deviation between the loci was observed. In the
analyses for the current study, as in the previous investigations
by de Toledo Ferraz Alves et al. (2011), we opted for taking into
account only the effect of the APOE allele 4. This was due to the
fact that the number of subjects was not large enough to address
the complexity of the combined effect of APOE alleles 2 and 4.
BRAIN IMAGES: ACQUISITION AND PRE-PROCESSING
Imaging data were acquired using a 1.5-T GE Sigma scanner
(General Electric, Milwaukee WI, USA), according to the fol-
lowing T1-SPGR protocol: (a) a dual-spin-echo sequence of 120
transaxial slices across the entire brain (axial PD/T2); (b) a T2-
weighted fast spin-echo transaxial sequence with 88 slices; and
(c) a three-dimension gradient echo (Spoiled Gradient Recalled
Acquisition–SPGR) sequence of 124 slices with TR/TE of 21.7/5.2
msec, flip angle of 20°, 220 mm field of view (FOV), 1.5 mm slice
thickness, number of measures (NEX) of 01, 256× 192 matrix. All
images were visually inspected by an experienced radiologist with
the purpose of identifying artifacts and presence of silent gross
brain lesions.
After quality inspection, T1 images were pre-processed using
DARTEL (Ashburner, 2007). Initially, segmentation was per-
formed in order to generate gray and white matter images of
each subject aligned via a rigid-body transformation. After seg-
mentation, templates were created in order to align gray and
white matters simultaneously across the images. Finally, images
were spatially normalized to MNI space and smoothed using a
Gaussian 8 mm FWHM. For this study, we used swc1 images (non-
modulated, normalized, and smoothed images) where each voxel
Table 2 | Demographic and clinical characteristics of the subjects in the sample analyzed.
Low risk (n=42) Medium risk (n=65) High risk (n=57) Statistical test p-Value
Mean age (±SD) in years 70.19±2.26 70.17±2.31 70.63±2.45 ANOVA 0.503
Male/female 9/33 23/42 44/17 χ2 <0.001
Mean years of education (±SD) in years 4.59±3.33 5.14±4.02 3.86±3.31 ANOVA 0.152
APOE_4 allele n (%) 9 (21.43%) 17 (26.15%) 10 (17.54%) χ2 0.516
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intensity represents the probability of containing GM. Before the
analysis, we applied a threshold of 0.15 to the GM probability maps
(i.e., voxels with less than 15% of probability of containing GM
were discarded in all images).
FRAMINGHAM SCORE AND OTHER CLINICAL ASSESSMENT
SCHEDULES
The FCHDR is a measure devised to synthesize the combination of
different CVRF in order to predict a major vascular-related event
(Grundy et al., 1998; Wilson et al., 1998). These CVRF include: age,
blood pressure, diabetes mellitus, smoking status, and cholesterol
levels (Korf et al., 2004; Lopez et al., 2008; Fitzpatrick et al., 2009;
Zivadinov et al., 2009; de Toledo Ferraz Alves et al., 2010; Rasgon
et al., 2011).
The clinical tools used to assess the individuals recruited for
the study included: measurements of fasting blood glucose levels,
with the presence of diabetes mellitus was defined by ≥126 mg/dl
and/or current use of insulin or hypoglycemic oral drug treatment;
levels of total cholesterol, and high density lipoprotein (HDL),
obtained using the cholesterol-oxidase method; and measures of
blood pressure,obtained in three measurements using an OMRON
digital sphygmomanometer; model HEM-712-C. Individuals with
high blood pressure were under antihypertensive treatment. For
the calculation of the arterial pressure value, the first measurement
was discarded, and the arithmetic mean of the second and third
measurements was calculated. Data regarding smoking habits were
provided by participant’s answers. More details regarding clinical
measurements can be obtained in de Toledo Ferraz Alves et al.
(2010) and Tamashiro-Duran et al. (2013).
PATTERN RECOGNITION
In the present paper, we used machine learning techniques, a
branch of artificial intelligence concerned with development of
algorithms able to evolve based on empirical data. Machine learn-
ing algorithms use examples (data) to capture characteristics of
interest from their underlying probability distribution (unknown
a priori). Data can be represented as observations (examples) that
contain relations among variables (features). In structural neu-
roimaging, each example is usually a scan (brain volume) from
a particular subject and features usually correspond to voxels
composing the images (or voxels composing a region of inter-
est anatomically defined). One of the major focuses of machine
learning relies on automatic recognizing complex patterns and
making decisions based on data (PR). Hence the learner algo-
rithm must generalize from the given examples, as well as to
be able to produce an output for new cases not used in the
training set.
Classification
One of the most common objectives of PR algorithms in machine
learning is classification, which attempts to assign each input value
to one of a given set of classes. In neuroimaging, classification
approaches have become increasingly popular in clinical research
due to their ability to produce individual predictions. In the con-
text of our problem, we hypothesize that the examples (brain
scans) of subjects belonging to the low-risk group can be dis-
criminated from the high-risk group with higher accuracy than in
classifications involving the medium-risk group.
In general, classification methods work as follows: given a set
of training examples, each one known to belong to a specific cate-
gory (class), the training algorithm learns a function based on the
values of each variable in the training set. The decision function
learnt is used to classify a new example (i.e., to predict the category
to which it belongs) based on to the values of their variables.
In neuroimaging, variables (features) composing the examples
usually correspond to voxels derived from a brain scan. Thus, usu-
ally each example comprises thousands of features. Although it is
not possible to visualize more than three dimensions, mathemat-
ically it is possible to conceive a hyperspace where each feature
is mapped into a different dimension. In this paper, we applied
support-vector machine (SVM) (Boser et al., 1992; Cortes and
Vapnik, 1995). The problem of obtaining a decision function in
SVM consists in finding a hyperplane (a plane in a hyperspace),
which has the largest margin between the closest examples across
classes (called support vectors).
Relation between classification projections and FCHDR
scores. In the current paper, we performed three binary classifica-
tions combining each of the three groups (two by two) (medium
versus low risk, high versus medium risk, and high versus low
risk). Additionally, as a binary classification may not be enough to
define precise predictions in some clinical applications (Sato et al.,
2008), we also performed a more exploratory analysis in order to
investigate the effect of the degree of cardiovascular risk (treated
as a continuous measure) in classifying the groups (categorical
information).
According to Sato et al. (2008), in many clinical applications, a
continuous index can be more informative than categorical labels,
as the distance from the classification boundary reflects predic-
tion reliability. These authors mention the example of AD studies
in which two groups of subjects (healthy subjects and patients)
are considered. In this case, it would be reasonable to expect that
the cognitive effects may vary across subjects; depending on the
disease stage (degree of dementia), similar levels of cognitive per-
formance might be present in some of the healthy subjects. In these
cases, a continuous variable representing the mental condition of
a subject might be considered.
Sato et al. (2008) take into account the fact that there are
intermediate observations (a group transition), so that categor-
ical observations might be localized in a continuum between two
groups. To illustrate this idea, they apply the maximum uncer-
tainty linear discriminant analysis approach (MLDA) hyperplane
navigation (Thomaz et al., 2006), specifying a procedure to project
multi-dimensional observations from different groups (categori-
cal label) into a continuum space, obtaining a score to measure the
distance of new observations to each group. This score is afterward
correlated to the real continual values (in their case, age in a group
of healthy subjects performing a motor task in fMRI).
Considering the idea explained above, we performed in the
present study a correlation analysis of the projection of the sam-
ples in the hyperplane with their FCHDR scores. The rationale is
to evaluate the link between brain image patterns and cardiovas-
cular risk information, based on the assumption that, in general,
the more extreme the risk, the further the sample would be distant
from the decision boundary.
Frontiers in Aging Neuroscience www.frontiersin.org December 2014 | Volume 6 | Article 300 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rondina et al. Decoding cardiovascular risks from brain
Regression
For classification analysis, subjects were categorized in three
groups according to their FCHDR scores. Although classification
is the most common PR approach used in neuroimaging, machine
learning techniques can also be applied to non-categorical data
through regression methods. This approach has great potential to
be applied in clinical researches involving continuous data (e.g.
population or physiological data, behavioral tests results, etc). In
this paper, we used support-vector regression [SVR (Drucker et al.,
1997; Smola and Schölkopf, 1998)], an algorithm similar to SVM
for classification, nevertheless applying different parameteriza-
tion. Instead of predicting a category to which an example belongs,
the objective here is to predict the clinical measure itself. Figure 2
shows a representation summarizing both the classification and
regression analyses presented in this paper.
The predictors for the analysis of single risk factors were nor-
malized (i.e., the mean value was subtracted from the original
values and results were divided by the SD). The normalization
enabled comparison of mean square errors (MSE) among differ-
ent single risk factors, as they were originally represented through
different measure units. MSE measures the average of the square
errors (i.e., the amount by which the value implied by the estimator
differs from the quantity to be estimated). Both classification and
regression methods were implemented using LIBSVM library1.
CROSS-VALIDATION FRAMEWORK
Cross-validation is a technique used to assess how the results of a
statistical analysis will generalize to an independent data set. One
round of cross-validation involves partitioning a data sample into
disjoint subsets of examples, performing the analysis on one subset
(the training set), and validating the analysis on the other subset
(the validation set or testing set).
To reduce the variability, multiple rounds of cross-validation
are performed using different partitions, and the validation results
are averaged over the rounds. In the present study, we implemented
a leave-one-out cross-validation (LOO-CV), which involves sep-
arating a single example from the original sample for validation
while the remaining examples are used as the training dataset.
This splitting is repeated in order that each example in the sample
is used once as the validation data. After repeating this process
leaving out all examples, the final accuracy was quantified as the
average of accuracies obtained across all iterations. In classifica-
tion, we left out one pair of examples (i.e., one subject from each
group) in each round so that the analysis was balanced between
the two groups. For regression analysis, one single subject was left
out at each round, as the objective is not a classification between
two groups.
STATISTICAL SIGNIFICANCE TESTING
We implemented permutation tests to evaluate whether the results
were statistically significant. This approach is a non-parametric
statistical test in which the distribution of the test under the null
hypothesis is obtained by calculating many possible combinations
under rearrangements of the labels (e.g., categories or clinical
1Chih-Chung Chang and Chih-Jen Lin, LIBSVM : a library for support vector
machines, 2001. Software available at http://www.csie.ntu.edu.tw/~cjlin/libsvm/
values) across the examples. It consists in randomly exchanging
the labels associated to the examples and repeating the complete
procedure a high number of times (e.g., 1000). As the correla-
tions between examples and labels are destroyed due to the labels’
permutation, one expects the classification accuracy to be close to
chance (around 50%).
The significance level is given by the number of times for which
the accuracy obtained from analysis with permuted labels is higher
than the accuracy obtained in the original analysis. The result-
ing number is divided by the number of repetitions to provide a
proportion value. The same approach is applied to regression, con-
sidering the correlation between real, and predicted labels instead
of accuracy.
RESULTS
CLASSIFICATION OF RISK GROUPS CATEGORIZED ACCORDING TO
FCHDR SCORES
As described in section “Study Sample,” we divided the individu-
als in three groups (low, medium, and high cardiovascular risk)
according to their FCHDR scores. In order to deal with unbalance
issues, we matched subjects by gender and age. This is important
to keep generalization ability, particularly in a cross-validation
approach. After matching subjects, we performed three binary
classifications: low versus medium risk (84 subjects), medium
versus high risk (74 subjects), and low versus high risk (44
subjects).
Given that the Framingham score takes into account age and
gender, we tried an alternative approach, considering all subjects
without matching. However, because of the different number of
subjects in each group, randomness was applied in the cross-
validation in order to select repeated subjects in the group with
less subjects. Using this approach, average accuracy was slightly
better, but there was a loss in generalization ability.
All the analyses were performed taking into account genetic
information regarding APOE-4 allele carriers (data used as a
covariate). In order to control for this effect, we applied a removal
of confound effects on the kernels using a residual form matrix, as
described in Chu et al. (2011).
Support-vector machine applied to classifications involving the
medium-risk group (i.e., low versus medium risk and medium
versus high risk) did not produce statistically significant results
according to the permutation tests. Accuracies of both analyses
were close to chance (Table 3), meaning that the classifiers were
not able to discriminate these groups. However, it was possible
to discriminate extreme groups (high versus low risk) with 75%
accuracy. The sensitivity (i.e., the proportion of individuals from
high-risk group correctly classified) was 82% and the specificity
(i.e., the proportion of individuals from low-risk group correctly
classified) was 68%. Permutation test showed this result was signif-
icant (p< 0.0001). Table 3 presents results from the three binary
classifiers.
Regarding the additional analysis described in sub-section
“Relation between classification projections and FCHDR scores”
above, the Pearson correlation value between FCHDR scores and
SVM projections in the classification between high and low-risk
groups was 0.788 (p≤ 0.0001). The same correlation for the classi-
fications involving the medium-risk group were 0.559 (p≤ 0.0002)
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FIGURE 2 | Representation of classification and regression analysis described along the paper.
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Table 3 | Results from SVM classification considering the three risk
groups in binary combinations.
Groups Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
Statistical
significance
Medium× low risk 38.10 59.52 48.81 ≤0.6390
High×medium risk 62.16 43.24 52.70 ≤0.3490
High× low risk 81.82 68.18 75 ≤0.0001
for high versus medium risk, and 0.609 (p≤ 0.0001) for medium
versus low risk.
Figure 3 presents three panels illustrating SVM classification
projections and correlation of these projections with FCHDR for
the three binary classifications – (A) low versus high risk; (B) low
versus middle risk; and (C) middle versus high risk.
REGRESSION ANALYSIS
In this section, we present results of the regression analysis without
categorization in risk groups, since we are interested in eval-
uating how accurately we can predict cardiovascular risk from
brain patterns. For regression, we also used a cross-validation
framework. However, only one subject is left out for test in each
iteration (instead of one pair of subjects), as we are not com-
paring groups (classes) of individuals. We start using FCHDR
scores as targets for regression. Next, in a more exploratory inves-
tigation we analyze risk factors that contribute to the FCHDR
score computation (diabetes, blood pressure, age, cholesterol, and
smoking status) in order to evaluate if there are factors that
stand out as more predictable from the brain patterns. Addition-
ally, we analyze data from male and female subjects separately,
as differences in gender have been reported in related literature
(Perneczky et al., 2007; Hsu et al., 2008; Ystad et al., 2009; Ander-
sen et al., 2010; Takahashi et al., 2011; Yao et al., 2012; Hall et al.,
2013).
All subjects
The result of the correlation between real FCHDR and pre-
dicted values was 0.2481 (p< 0.001) with MSE 1.0564 (p< 0.001).
In Figure 4, a scatter plot represents this correlation, where
each subject is plotted with real FCHDR score placed in the x-
axes and predicted score placed in the y-axes. Individuals were
plotted in different colors according to gender. The color cod-
ing offers an initial insight regarding the existence of gender
differences in relation to the association of brain patterns to
CVRF.
Besides the application of SVR to learn relations between
brain patterns and the combined measure of cardiovascular risks
(FCHDR score), we also evaluated whether it is possible to pre-
dict single risk factors from relations learned from brain patterns.
Results are presented in Table 4. No single factor presented sig-
nificant results of the correlation between real and predicted
variable. As regards dichotomic diabetes (derived from glycemia),
we applied classification to evaluate whether is possible to discrim-
inate diabetic and non-diabetic individuals. Like the other single
risk factors, results for diabetes were not significant (classification
accuracy= 55%, p= 0.22).
Gender differences
Figure 4 suggests that there is a potential difference in the ability of
predicting FCHDR from brain patterns according to gender. As the
FCHDR score was devised through different calculation for male
and female individuals (see Study Sample), we also performed the
regression analysis separately for male and female individuals. The
correlation between real and predicted FCHDR scores in females
was 0.4044 (p< 0.001). However, in males this correlation was not
significant.
Table 5 presents results of analyses performed separately in
females and males. For females, age and smoking status could be
predicted from brain patterns. Blood pressure also stood out, but
the statistical significance of its accuracy was slightly above the
considered threshold of 0.05. For males, no single factor could be
predicted (Table 5).
APOE 4 ALLELE DIFFERENCES
The presence of APOE 4 allele is associated with an increased risk
not only for dementia but also for cardiovascular disease. There-
fore, the APOE-4 allele carrier can be a confound factor for the
analyses. It is important to evaluate if the correlation between
real and predicted FCHDR scores remains significant if the APOE
genotyping is included in the model as a covariate. In the analy-
ses performed using all subjects (males and females), the results
retained significance for FCHDR score (r = 0.1961, p= 0.007).
Regarding the analysis performed only with female individuals,
both FCHDR score and age retained significance when the genetic
data was included as covariate in the model.
Regression analysis in APOE4 carriers and non-carriers separately
In our database, 36 individuals carry at least one APOE-4 allele.
We selected a group consisting of 36 non-allele 4 carriers from the
same database matching according to gender, age, and FCHDR
score. We performed regression analysis separately for carriers and
non-carriers using FCHDR as target. The correlation between real
and predicted FCHDR was 0.4240 (p= 0.003) for carriers and
0.2937 (p= 0.041) for non-carriers.
Figure 5 presents a map of the relative weights of each voxel
resulting from regression of brain patterns using FCHDR scores
as targets in the analyses performed with carriers (Figure 5A) and
non-carriers (Figure 5B).
Regarding the map, it is important to observe that due to the
fact that the analysis is multivariate, the combination of all voxels
is identified as a global spatial pattern by which the groups dif-
fer (i.e., the discriminating pattern). As all voxels contribute to the
classification in some degree, it is not appropriate to make regional
inferences based on single voxels or regions separately from the rest
of the pattern.
DISCUSSION
Recent literature on neuroscience related to aging processes has
shown increasing evidence of the impact of CVRF on cognitive
performance (Launer et al., 2000; Knopman et al., 2001; Korf et al.,
2004; Stuerenburg et al., 2005; Irie et al., 2008; Lopez et al., 2008;
Erkinjuntti and Gauthier, 2009; Fitzpatrick et al., 2009; Zivadinov
et al., 2009; Rasgon et al., 2011; Rouch et al., 2012; Watts et al.,
2013). Recent studies have also applied neuroimaging resources
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FIGURE 3 | Each panel presents SVM projections resulting from a binary
classification: (A) Low versus medium risk; (B) Medium versus high risk;
(C) Low versus high risk. On the left-hand side in each panel, the plot shows
the classification projection in colors representing the real class of each
subject. As a convention, in each classification, the lower risk class was
labeled with −1 and the higher class was labeled as 1. Thus, subjects with
negative projections are classified as belonging to the lower risk class and
subjects with positive projections are classified as belonging to the higher risk
class. From these plots, it is possible to notice that the numbers of correct
classifications in (A,B) are very close to chance. In (C), it is possible to notice
that most low-risk subjects have negative projections and most high-risk
subjects have positive projections (which results in the accuracy of 75%
described in Section “Classification of Risk Groups Categorized According to
FCHDR Scores.” Nevertheless, for all classifications there was significant
correlation between SVM projections and FCHDR for the subjects correctly
classified (illustrated in the plots on the right-hand side in each panel).
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in order to show that structural brain changes (e.g., GM loss) are
associated to different CVRF (e.g., glycemia level, blood pressure,
age, cholesterol levels), separately or in composite measures (Xu
et al., 2009; Glodzik et al., 2012).
FIGURE 4 | Scatter plot of correlation between real and predicted
FCHDR score codified in colors according to the gender. Please notice
that this analysis was performed considering all subjects (male and female).
The colors code (red for female and blue for male) was used in order to
provide a better visualization regarding the gender difference observed in
the results.
Table 4 | Regression with single risk factors.
R p(R ) MSE p(MSE)
FCHDR 0.2481 <0.001 1.0564 <0.001
Blood pressure 0.0753 0.215 1.1498 0.216
Age 0.0052 0.424 1.2408 0.517
Total cholesterol −0.0212 0.529 1.3400 0.821
LDL cholesterol −0.0475 0.642 1.3417 0.822
Smoking status 0.1628 0.057 1.0698 0.067
R is the correlation between real and predicted values and MSE is the mean
squared error. The statistical significance (p) was estimated for both R and MSE.
In the present paper, we aimed to decode cardiovascular risk
information from image patterns. In our context, decoding mod-
els (or recognition models) related changes in brain pattern
(independent variable) to CVRF (dependent variable).
Multivariate approaches can reveal information jointly encoded
by all features considered (as a network). Additionally, they
can provide predictions in individual level. To the best of our
knowledge, this is the first study using PR techniques to investi-
gate the effect of CVRF on the brain based on structural MRI.
We hypothesize that brain changes caused by a combination of
CVRF risks encompass different brain regions. Thus methods
that take into account the joint effect of all voxels in the whole
brain can be more sensitive to detect changes than univariate
methods.
In the classification of groups categorized according to FCHDR
scores, it was possible to discriminate the extreme groups (low ver-
sus high risk) with statistical significance. However, it should be
noted that the indices of diagnostic accuracy obtained were con-
siderably more modest than the accuracy levels found in studies
of AD or minor cognitive impairment (Fan et al., 2008; Cui et al.,
2011; Davatzikos et al., 2011; Diciotti et al., 2012; Westman et al.,
2012). This provides indication that the impact of CVRF in the
cognitively preserved elderly population is subtle, even when one
applies multivariate statistical approaches of improved sensitivity
such as the one employed herein. Regarding the medium group
risk, classification in relation to both low and high-risk groups
resulted in lower accuracy levels and permutation tests showed
these results were not statistically significant. This again under-
scores the subtlety of the impact of CVRF on brain volumes in
cognitively preserved elderly individuals. Medium-risk individu-
als presented a higher homogeneity in their brain patterns, and
this may have prevented their discrimination from the extreme
(low and high) risk groups.
This hypothesis is reinforced by the difference in the num-
ber of subjects correctly classified in each group in the above
mentioned analyses. In high versus medium risk, 62% of the high-
risk subjects were correctly classified compared to 43.24% in the
medium-risk group. In the same way, in medium versus low risk,
38.10% of the medium-risk subjects were correctly classified and
compared to 59.52% in the low-risk group. By correlating FCHDR
rates of subjects correctly classified to their respective classification
projections, it was possible to observe this inhomogeneity in the
asymmetry of projections in Figures 3A,B.
Table 5 | Regression with single risk factors.
R p(R ) MSE p(MSE) R p(R ) MSE p(MSE)
FCHDR 0.4044 <0.001 0.8323 <0.001 −0.0057 0.424 1.1999 0.580
Blood pressure 0.2309 0.054 0.9685 0.052 −0.1945 0.850 1.3054 0.818
Age 0.2776 0.033 0.9379 0.035 0.1182 0.201 1.0267 0.136
Total cholesterol −0.0478 0.540 1.1960 0.504 −0.0177 0.441 1.2608 0.702
LDL cholesterol −0.1264 0.755 1.2691 0.725 −0.0376 0.480 1.2206 0.605
Smoking status 0.3480 0.008 0.8705 0.007 −0.0894 0.633 1.2826 0.780
R is the correlation between real and predicted values and MSE is the mean squared error. Statistical significance (p) was estimated for both R and MSE. These
analyses were performed separately in females (left in the table) and males (right).
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FIGURE 5 | Map showing the relative weight of each voxel in the multivariate regression (SVR) of images using FCHDR scores as targets. Separate
analysis was performed for APOE4 allele carriers (A) and non-carriers (B).
The above findings provide indication that the images from
subjects categorized in three groups apparently are not homo-
geneous enough to discriminate intermediate subjects (medium
risk) from low and high-risk subjects. Conversely, given the fact
that the correlation between FCHDR rates with their classifica-
tion projections is high and significant for the three comparisons,
our data also indicate that the patterns carry relevant, continuous
information regarding the impact of cardiovascular risk on the
brain.
Complementary to the classification based on categorized
groups, we applied multivariate regression to the complete dataset
(without categorization) in order to decode continuous mea-
sures from the brain images. This analysis aimed at investigating
to what degree brain changes associated to cardiovascular risk
are detectable from structural MRI. Using SVR (Support-Vector
Regression), parameters were learned from the training subjects’
images. These parameters were used to predict a continuous value
for the test subject. Applying SVR in a LOO-CV framework pro-
duced a set of predicted values, which was correlated with the set
of real values. This correlation was evaluated regarding statistical
significance using permutation tests.
Through SVR analysis considering all subjects (both male
and female), it was possible to predict the FCHDR score with
high statistical significance (p< 0.001). This result suggests that
anatomical brain changes detectable from MRI images seem to
clearly reflect different levels of cardiovascular risk given by the
Framingham score. On the other hand, by exploring each risk fac-
tor isolated (diabetes, blood pressure, age, total cholesterol, and
smoking status), none of them presented significant correlation
between real and predicted values. Thus, the SVR analysis allowed
us to empirically confirm that brain volume variations predict
best the combined influence of different CVRF (as assessed with
Framingham scores), rather than by any of the single factors when
considered in isolation.
Results of the analyses performed separately in men and
women were remarkably different. The correlation between real
and predicted FCHDR scores in females was much higher than
the correlation obtained when considering the entire popula-
tion. Additionally, this correlation was not significant when males
were considered separately. This is interesting in light of the fact
that clinical and epidemiological studies strongly indicate that
the prevalence is greater and the outcome is poorer for cardio-
and cerebro-vascular disorders in males (Grundy and Jett, 1959;
Plavinskaia and Shestov, 1991; Kameneva et al., 2003; Khaksari
et al., 2005; Moran et al., 2008). Although gender differences have
already been reported in previous studies, the magnitude of these
differences in our results suggest that future investigations need
to be carried out in order to afford a better understanding of
their fundamental basis. However, the gender imbalance in our
dataset may contribute for this effect, as men predominate in
high-risk group. There was an excess of males from our overall
epidemiological cohort that could not be included since previ-
ous phases of the investigation due to overt neurological and
cerebrovascular-related diseases. Therefore, it is likely that our
study design privileged the inclusion of a sub-sample of males
with high cardiovascular risk that is less representative of the gen-
eral elderly population, and this would have exerted an impact on
the statistical significance of our findings for males.
When exploring single risk factors in females separately, it was
interesting to observe that although two single risk factors (age and
smoking status) were significantly predicted, only age remained
significant when including the genetic risk factor (the APOE4
allele) as covariate in the model. This finding corroborates once
again the importance of considering cardiovascular risks factors
jointly when studying their effects on structural brain changes.
Albeit statistically significant, the correlation rates between
actual FCHDR scores and values predicted from regression
were modest (r = 0.2481when considering both male and female
together, and r = 0.4044 when considering only female subjects).
Although in the literature, there are examples where this corre-
lation is very high (e.g., r = 0.92 in decoding age from structural
MRI from healthy individuals, Franke et al., 2010), there are also
examples of applications where the decoding affords low correla-
tions, although still significant (ex. r = 0.49 to predict years from
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onset in Huntington disease, Rizk-Jackson et al., 2011). In our
investigation, we are searching for brain alterations due to car-
diovascular risk that are presumably subtle, in individuals that are
unaffected by neurological or psychiatric disorders and cognitively
unimpaired. Although there is evidence in the previous literature
suggesting that the individuals with higher FCHDR are more likely
to develop AD in the future, it should be noted that at the time the
individuals are scanned in our study design, they do not present
any symptoms. We believe that the nature of this decoding plays
a role in explaining why the correlation between the real and pre-
dicted values is not as high as they could be if we were investigating
patients actually suffering from dementia.
The results of analyses taking into account the presence of the
APOE 4 allele suggest the impact of this genetic variation on brain
volumes. This is consistent with the findings of a number of pre-
vious MRI studies (Yasuda et al., 1998; Hashimoto et al., 2001;
Lind et al., 2006; Crivello et al., 2010; Liu et al., 2010; Fennema-
Notestine et al., 2011; Lu et al., 2011; Bender and Raz, 2012; Bunce
et al., 2012; O’Dwyer et al., 2012; Dowell et al., 2013). It is interest-
ing that the analysis showed different signatures for CVRF-related
brain variations inAPOE-4 allele carriers and non-carriers. A sim-
ilar difference had already been shown in previous MRI and PET
studies that used univariate image analysis methods (Kuller, 2003;
Zipser et al., 2007; Deeny et al., 2012; Lo and Jagust, 2012), but this
had never been previously demonstrated using the multivariate PR
approach as shown herein. Additionally, it is interesting to notice
that although analysis in APOE 4 carriers showed higher corre-
lation between real and predicted FCHDR (indicating that the
presence of the APOE 4 allele modulates the influence of CVRF
on regional brain volumes), the correlation obtained from analy-
sis with non-carriers was also significant. This result reinforces
the initial hypothesis that CVRF of non-genetic origin also lead to
detectable brain changes.
Regarding localization of brain alterations, caution must be
exercised when drawing conclusions in regard to the description
of the brain regions that contribute to each of the discriminative
patterns reported herein. Although the maps enable to visualize
the relative relevance of each voxel in predicting the labels, these
predictions depend on the whole pattern, so it is not possible to
assign results to single brain regions.
In conclusion, our results endorse the suggestion that the sever-
ity of the Framingham score for combined cardiovascular risk is
related to brain volume changes detectable through global patterns
from structural MRI data, when a pattern classification approach
is applied. Additionally, these brain changes seem to be actu-
ally modulated by the presence of the APOE 4 allele but remain
detectable when this genetic variable is included in the models
as a covariate, suggesting that environmental factors and other
genetic influences also play an important role in the emergence
of brain changes associated to the degree of cardiovascular risk.
The discrimination between individuals with low and high car-
diovascular risk hints at a potential clinical usefulness of pattern
classification methods to assess the impact of CVRF on the brain
on an individual basis. It is important that further studies are
conducted to confirm this possibility, given that CVRF are pre-
ventable and modifiable, and so are likely to be their effects on the
brain.
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